SCHEMBL20580955

SCHEMBL20580955

I[Zn]I.[Zn]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6553 0.89
SCHEMBL22462421 0.80
SCHEMBL1628467 0.55
SCHEMBL6937048 0.45
SCHEMBL50 0.45
SCHEMBL10698912 0.45
SCHEMBL9144971 0.45
SCHEMBL713458 0.45
Potassium Iodide SCHEMBL22616409 0.45
Charcoal, Activated SCHEMBL8562816 0.45

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110678468-B 5, 6-fused bicyclic compounds and compositions thereof for the treatment of parasitic diseases 诺华股份有限公司 2022-07-29 CN disclosed
CN-110678468-A 5, 6-fused bicyclic compounds and compositions thereof for the treatment of parasitic diseases 诺华股份有限公司 2020-01-10 CN disclosed
WO-2018231782-A2 METAL COMPLEXES AS PHARMACEUTICALS FOR TREATMENT AND PREVENTION OF CANCER AND INFLAMMATORY DISEASES UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2018-12-20 WO disclosed
US-20180353539-A1 METAL COMPLEXES AS PHARMACEUTICALS FOR TREATMENT AND PREVENTION OF CANCER AND INFLAMMATORY DISEASES UNIV SOUTHERN CALIFORNIA (US) 2018-12-13 US disclosed